Carlsbad, California
United States
28
2025-06-12
The entities that hold a legal rights for patent applications filed by inventor Papa Patrick:
Patrick Papa from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#2 | 2024-11-07ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#3 | 2024-06-20SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#4 | 2024-06-13KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#5 | 2024-06-13KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#6 | 2024-05-30SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#7 | 2024-04-18PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
#8 | 2024-01-25SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
#9 | 2023-10-26ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
#10 | 2023-09-21QUINAZOLINES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
#11 | 2023-04-20PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
#12 | 2020-08-20Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
#13 | 2019-03-14Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
#14 | 2017-11-30Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
#15 | 2016-12-08Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#16 | 2016-01-28Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
#17 | 2015-09-03Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#18 | 2015-06-25Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
#19 | 2015-02-19Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
#20 | 2014-06-05Methods of synthesis and purification of heteroaryl compounds
#21 | 2013-10-31Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
#22 | 2013-09-19Methods of synthesis and purification of heteroaryl compounds
#23 | 2013-01-03AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
#24 | 2012-03-22Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
#25 | 2012-03-08Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
#26 | 2011-06-09Methods of synthesis and purification of heteroaryl compounds
#27 | 2010-08-26Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
#28 | 2010-04-15Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
13847 ⎘